Relevance. Dysbiotic disorders and genital herpes are common among women of childbearing age, determines the urgency of enhancing the effectiveness of the treatment of these conditions. Purpose -evaluation of probiotics efficacy in complex therapeutic and preventive measures for pregnant women with herpesvirus infection. Patients and methods. The main group -30 pregnant women with herpes infection to whom the complex of preventive measures with Florium probiotic containing 4 strains of lactobacilli was used; the comparison group -30 pregnant women with prenatal care according to the Ministry of Health reports. The microscopic and cultural methods of examination were used in the studies of vaginal microecology. The intestine biocenosis disturbance level was evaluated by using cultural method and standard techniques.
Introduction
It is known that the mother is the main source of colonization of both normal and pathogenic microorganisms for a newborn. Recently, there are many pregnant women with bacterial vaginosis (20-25%). Bacterial vaginosis is one of the forms of vaginal microecology dysbiotic disorders caused under the influence of exogenous and endogenous factors. It is especially relevant for women with immunosuppression and herpesvirus infection particularly. From a position of microbiology, bacterial vaginosis should be treated as infectious inflammatory syndrome characterized by high levels of obligate anaerobes and sharp reduction of lactobacilli or their absence in the vaginal environment. It was proven that such imbalance of vaginal microflora in obstetric practice causes placental insufficiency, premature birth, growth retardation, postpartum endometritis and other obstetric complications [3] . Vaginal microbiota should not be considered as an isolated biotope, but in conjunction with a microbiome evaluation in women. Physiological immunosuppression during pregnancy and herpesvirus infection and alteration of acidity under the influence of gestation hormones disturb the microbial balance of biocenosis in all mucous membranes of the pregnant woman. Intestinal dysbacteriosis is revealed in 50-55% of women suffering from bacterial vaginosis. This dysbacteriosis testifies to the common dysbiotic process in the body with a dominant manifestation either in the genital or in the digestive system. The intestine is a reservoir for microorganisms associated with bacterial vaginosis. Severe intestinal dysbiosis may cause not only abnormal pregnancy and childbirth, but may also determine the formation of intestinal biocenosis in newborns. The intestine therefore is considered as a "target" for pathogenetic therapy [6] . For today the questions about the effect of combined disorders of vaginal and intestinal microbiocenosis on the development of obstetric and perinatal complications has not been sufficiently studied. Due to the lack of efficacy of therapeutic and preventive measures, it is necessary to look for preventive measures aimed at increasing resistance to infection of pregnant women. The necessity to study and to treat mixed bacterial and viral infections of the lower genital tract (vulvovaginitis, cervicitis and bacterial vaginosis) and genital herpes infection is caused by their significant prevalence, insufficient efficacy of existing treatments associated with not quite studied processes of development of disease, drugs resistance, prolong course with frequent relapses and chronic process. A particular epidemiological threat is women asymptomatic herpes that causes the infection of the fetus, an increased number of spontaneous abortions, premature births and newborns with central nervous system disorders. Prolong herpesvirus persistence in humans and specific immunodeficiency generated in patients with recurrent genital herpes cause the addition of other urogenital tract infections [5] . Considering the fact that dysbiotic disorders and genital herpes are common in women of childbearing age, it is clear that the improvement of the efficiency of the treatment of these conditions through improved pathogenetically reasonable methods of therapy is very important. Bacterial and viral pathogens have different effects on the state of immune resistance of the body. So if most opportunistic pathogens increase the tension of anti-infectious general and local immunity, then the viral disease have mosaic pattern of immunogenesis disorders due to pronounced ability of viruses to block the synthesis of protective proteins and functional activity of certain types of immune cells, which in turn reduces the effectiveness of the treatment and makes it incomplete [ 2] .
Probiotics -the drugs containing live strains of normal intestinal microflora, plays a leading role in the normalization of intestinal microflora. Probiotics have an antagonistic effect against abnormal strains of intestinal microflora. It is caused by the action of metabolites of the normal bacteria, the most important of which are short chain fatty acids and lactic acid. Probiotics not only prevent colonization of pathogens, but also contribute to the stabilization of the epithelial barrier as well as prevent translocation of bacteria into the internal environment. The stimulation of the immune response of mucosa of gastrointestinal tract and other organs plays an important role in the mechanism of action of probiotics [1, 4] . Purpose -the evaluation of probiotics efficacy in complex treatment and preventive measures for pregnant women with herpesvirus infection.
Materials and methods
To test the efficacy of probiotics in complex treatment and preventive measures we have selected 60 pregnant women with herpesvirus infection (HVI) on the 14-16 th week of pregnancy. These 60 women were divided into two groups randomly: the main group -30 pregnant women to whom the recommended complex of preventive measures with probiotics was used; the comparison group -30 pregnant women with prenatal care according to the Ministry of Health reports. The control group involved 50 healthy pregnant women with the appropriate period of pregnancy but without HVI. The microscopic and cultural methods of examination were used in the studies of vaginal microecology. When comparing the results obtained with the use of Kira's classification to prove the cultural studies and clinical parameters we recorded four types of condition of vaginal biocenosis: normocenosis, moderate normocenosis, moderate dysbiosis and expressed dysbiosis. The intestine biocenosis disorder level was evaluated in accordance with the guidelines "Diagnosis and Treatment of intestinal dysbacteriosis" (Moscow, 1991). Quantitative analysis of microflora was studied by seeding of serial cultivations of 1 cm 3 of material on the surface of solid differential-diagnostic mediums: egg-yolk salt agar, blood agar, Saburo medium for fungi, thioglycolic medium, Endo's and Ploskiryev's medium, Medium Blaurock (bifidobacteria) and MRS medium (lactobacilli) were used to study the normal microflora. Quantitative parameters of bacterial growth were converted to decimal logarithms. Oral symbiotic Florium was included in the complex of treatment to restore the microflora of the vagina and intestine. The preparation is easy to use; it does not require any special instructions for use; the course of treatment is 1 week. Florium is a patented food supplement (European Patent PCT / EP2011 / 065877) in the form of capsules containing four strains of lactic acid bacteria that restore and maintain the balance of vaginal flora: -Lactobacillus crispatus LBV88 no less than 100h109 CFU/g -40 mg; -Lactobacillus rhamnosus LBV96 no less than 100h109 CFU/g -40 mg; -Lactobacillus gasseri LBV150 no less than 100h109 CFU/g -12 mg; -Lactobacillus jensenii LBV116 no less than 100h109 CFU/g -8 mg.
In addition to Lactobacillus the composition of Florium contains fructooligosaccharides which is a breeding ground for the growth and reproduction of its own microflora. Method of administration and dosage: 1 capsule twice a day (in the morning and in the evening) 30 minutes before meals, drink water or other beverage. Duration of use is 1 week.
Results and discussions
After the treatment with probiotics the intestinal microecology of the women from the main group has been improved as evidenced by the reduced incidence of pathogens sowing. The incidence of sowing of Proteus (20.0% to 10.0%), Staphylococcus aureus (16.7% to 6.7%) fungus Candida spp. (36.7% to 16.7 %, p <0,05) was decreased by 2 times. According to the Table 1 , bifidobacteria and lactobacilli concentrations in the women of the main group have been increased. Thus, the number of lactobacilli in women after treatment was 6,8 ± 0,4 Lg CFU/ml versus 4,3 ± 0,5 Lg CFU/mL before treatment (p <0,05), bifidobacteria -6,6 ± 0, 6 Lg CFU/ml versus 4,3 ± 0,4 Lg CFU/ml, respectively (p <0,05). Against the background of dominant flora growth the reduction of opportunistic pathogens was recorded: in the women of the main group the significantly low concentrations of hemolytic Escherichia circle, however, Staphylococcus aureus, Klebsiella and fungi of Candida spp. were recorded. According to the analysis of laboratory and clinical parameters, the proportion of women of the main group with intestinal dysbiosis of various severity was decreased from 66.7% to 46.7%.
Before treatment 40.0% of women with HVI complained about intestinal dysbiosis clinical manifestations, the most common of which were abdominal discomfort, constipation and mucus in feces. After the recommended treatment these complaints were observed only in 12.0% of pregnant women. As a result of complex treatment of women of the main group the microbial landscape of the vagina was improved. When a significant inhibition of normal microflora was recorded in the treatment of women of both the main group and the comparison group, then after the course the situation has improved. Thus, before the treatment bifidobacteria (CFU at 104 and above) were detected only in 10.0% and 13.3% of women of the main group and the comparison group, but after the recommended treatment the rate was increased up to 40,0% (p <0,05), and in the women of the comparison group, it remained at the same level (16.7%). Before the treatment Lactobacilli, which presence is essential for diagnosis of vaginal biocenosis, were detected in 13.3% and 16.7% of women, respectively, but after treatment they were detected in 46,7% (p <0,05) and 20,0%. As a result the incidence of sowing of significant levels of pathogenic and opportunistic pathogens was decreased (Staphylococcus aureus and hemolytic, gardnerellas, chlamydia, ureoplasma, mycoplasma and fungi of Candida spp.). 
